» Articles » PMID: 30368901

The Salmonella Pathogenicity Island-2 Subverts Human NLRP3 and NLRC4 Inflammasome Responses

Overview
Journal J Leukoc Biol
Date 2018 Oct 29
PMID 30368901
Citations 26
Authors
Affiliations
Soon will be listed here.
Abstract

Inflammasomes are signaling hubs that activate inflammatory caspases to drive cytokine maturation and cell lysis. Inflammasome activation by Salmonella Typhimurium infection or Salmonella-derived molecules is extensively studied in murine myeloid cells. Salmonella-induced inflammasome signaling in human innate immune cells, is however, poorly characterized. Here, we show that Salmonella mutation to inactivate the Salmonella pathogenicity island-2 type III secretion system (SPI2 T3SS) potentiates S. Typhimurium-induced inflammasome responses from primary human macrophages, resulting in strong IL-1β production and macrophage death. Inactivation of the SPI1 T3SS diminished human macrophage responses to WT and ΔSPI2 Salmonella. Salmonella ΔSPI2 elicited a mixed inflammasome response from human myeloid cells, in which NLR family CARD-domain containing protein 4 (NLRC4) and NLR family PYRIN-domain containing protein 3 (NLRP3) perform somewhat redundant functions in generating IL-1β and inducing pyroptosis. Our data suggest that Salmonella employs the SPI2 T3SS to subvert SPI1-induced NLRP3 and NLRC4 inflammasome responses in human primary macrophages, in a species-specific immune evasion mechanism.

Citing Articles

OspF blocks rapid p38-dependent priming of the NAIP-NLRC4 inflammasome.

Turcotte E, Kim K, Eislmayr K, Goers L, Mitchell P, Lesser C bioRxiv. 2025; .

PMID: 39975412 PMC: 11838452. DOI: 10.1101/2025.02.01.636075.


Strategies of bacterial detection by inflammasomes.

Jastrab J, Kagan J Cell Chem Biol. 2024; 31(5):835-850.

PMID: 38636521 PMC: 11103797. DOI: 10.1016/j.chembiol.2024.03.009.


Enteritidis antitoxin DinJ inhibits NLRP3-dependent canonical inflammasome activation in macrophages.

Gu D, Li A, Zang X, Huang T, Guo Y, Jiao X Infect Immun. 2024; 92(4):e0050523.

PMID: 38477589 PMC: 11003228. DOI: 10.1128/iai.00505-23.


Divergent functional outcomes of NLRP3 blockade downstream of multi-inflammasome activation: therapeutic implications for ALS.

Clenet M, Keaney J, Gillet G, Valadas J, Langlois J, Cardenas A Front Immunol. 2023; 14:1190219.

PMID: 37575265 PMC: 10415077. DOI: 10.3389/fimmu.2023.1190219.


Inflammasomes primarily restrict cytosolic replication within human macrophages.

Egan M, ORourke E, Mageswaran S, Zuo B, Martynyuk I, Demissie T bioRxiv. 2023; .

PMID: 37503120 PMC: 10370064. DOI: 10.1101/2023.07.17.549348.